Hedy Kindler to Thrombospondin 1
This is a "connection" page, showing publications Hedy Kindler has written about Thrombospondin 1.
Connection Strength
0.105
-
Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107). Lung Cancer. 2012 Jun; 76(3):393-6.
Score: 0.105
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.